December 04, 2025

FDA Approves Biologic for Nerve Repair

A newly licensed biologic offers a novel approach to repairing complex peripheral nerve injuries across pediatric and adult populations.

Conexiant

December 04, 2025

HHS Communications in Transition

Why HHS messaging is shifting, and what it means for patient trust.

KFF Health News

December 03, 2025

Pazdur Exit Triggers Agency Concerns

Recruitment of Pazdur was intended to stabilize the center after these departures.

Conexiant

December 03, 2025

Are New Incentives Boosting Births?

A report on recent federal pronatalist policy initiatives, proposed IVF access measures, and associated government actions involving women’s and children’s health programs in the US.

KFF Health News

December 02, 2025

FDA Clears Rapid Bordetella PCR Test

The assay detects and differentiates key Bordetella species at the point of care, providing rapid results that support timely pertussis evaluation.

Conexiant

November 25, 2025

FDA OKs First SMA Gene Replacement Therapy

The FDA approved Itvisma, the first gene replacement therapy for children 2 years and older, teens, and adults with spinal muscular atrophy, a one-time treatment that replaces the SMN1 gene and demonstrated improved motor function in Phase 3 studies.

Conexiant

November 24, 2025

‘It Should Have Never Been Published’ Debate Continues

Experts counter Robert F. Kennedy Jr.’s claims about aluminum adjuvant safety, noting extensive evidence that aluminum-containing vaccines remain effective and well-validated.

KFF Health News

November 24, 2025

Why Youth E-Bike Injuries Are Increasing

Rising youth e-bike use and injuries amid limited federal oversight and evolving state safety rules.

KFF Health News

November 21, 2025

‘Gold-Standard Science’ Meets a Rewrite

Revisions to a key CDC webpage have unsettled clinicians, who worry the changes could erode confidence in established vaccine science.

KFF Health News